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ABSTRACT 
Background 
Throughout Asia there is an unprecedented link between cholangiocarcinoma and infection 
with the liver fluke Opisthorchis viverrini. Multiple processes including chronic inflammation 
and secretion of parasite proteins into the biliary epithelium drive infection towards cancer. 
Until now, the mechanism and effects of parasite protein entry into cholangiocytes was 
unknown. 
Methods 
Various microscopy techniques were used to identify O. viverrini extracellular vesicles (EVs) 
and their internalization by human cholangiocytes. Using mass spectrometry we characterised 
the EV proteome and associated changes in cholangiocytes after EV uptake, and detected EV 
proteins in bile of infected hamsters and humans. Cholangiocyte proliferation and IL-6 
secretion was measured to assess the impact of EV internalization.  
Results 
EVs were identified in fluke culture medium and bile of infected hosts. EVs internalized by 
cholangiocytes drove cell proliferation an  IL-6 secretion and induced changes in protein 
expression associated with endocytosis, wound repair and cancer. Antibodies to an O. 
viverrini tetraspanin blocked EV uptake and IL-6 secretion by cholangiocytes.  
Conclusions 
This is the first time that EVs from a multicellular pathogen have been identified in host 
tissues. Our findings imply a role for O. viverrini EVs in pathogenesis and highlight an 
approach to vaccine development for this infectious cancer. 
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Introduction 
The liver fluke, Opisthorchis viverrini, is classified as a group 1 carcinogen by the 
International Agency for Research on Cancer, and is a major public health problem in many 
parts of Southeast Asia. In Northeast Thailand alone, more than 8 million people harbour the 
parasite [1] due to traditional dietary preferences for eating uncooked fish that harbour the 
infective stage of the fluke [2]. Upon ingestion of infected fish, the metacercariae excyst in 
the duodenum and migrate to the bile ducts of the definitive host where they feed on the 
biliary epithelia. Infection is associated with a spectrum of hepatobiliary abnormalities 
including bile duct cancer or cholangiocarcinoma (CCA) [2, 3]. The incidence of CCA in 
Northeast Thailand is substantially higher than elsewhere in the world, and associates 
strongly with the prevalence of O. viverrini infection [4].  
The mechanisms involved in liver fluke-driven tumorigenesis are multi-factorial, with 
apparent roles for (i) mechanical damage caused by parasites grazing on the biliary 
epithelium; (ii) chronic immunopathologic processes that are dominated by pro-inflammatory 
cytokines such as IL-6 [1]; (iii) the active release of parasite-derived excretory/secretory (ES) 
products into the bile ducts that drive unchecked cell proliferation [2, 5-7]. Intriguingly, some 
of these ES products have been identified inside cholangiocytes of experimentally infected 
hamsters [6, 8, 9], akin to the intracellular presence of the CagA protein from another 
carcinogenic pathogen, Helicobacter pylori [10]. Until now, the mechanisms by which liver 
fluke ES proteins are internalized by cholangiocytes, and the ramifications of this process for 
the host cell, have remained unknown. 
Recent reports have highlighted the presence of secreted extracellular vesicles (EVs) 
from parasites of both unicellular [11, 12] and multicellular (helminths) [13-15] origin, and 
provide a plausible explanation for the abundance in helminth ES products of apparently 
“intracellular” proteins [16]. EVs are small membrane-enclosed structures that are released by 
many different cell types [17, 18]. EVs from unicellular parasites have been shown to 
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influence host physiological processes, including immunomodulation, and adherence and 
communication between host and parasite [12, 19, 20]. A recent report described the uptake 
of parasitic platyhelminth EVs by host cell lines in vitro using low resolution fluorescence 
microscopy [13], but the molecular impact of EV uptake on the recipient cell, and detection 
of helminth EVs in vivo has until now, not been reported.  
Here we show that O. viverrini secretes EVs that induce a pro-
inflammatory/tumorigenic phenotype in human cholangiocytes. We also show that cellular 
uptake of O. viverrini EVs can be blocked by antibodies to an EV recombinant tetraspanin, 
highlighting the potential utility of EV proteins as vaccines to prevent fluke infection and 
associated cholangiocarcinogenesis. 
 
Materials and Methods  
Ethics statement 
Hamsters were maintained at Khon Kaen University (KKU), Thailand. The study was 
approved by the KKU Animal Ethics Committee (AEKKU 55/2554). Human bile was 
collected under an approved protocol (HE 521209) from the KKU Institutional Review Board. 
 
Parasite material, isolation of ES products and EV purification 
Parasites were obtained from experimentally infected hamsters and ES products were 
isolated as described [8]. EVs were purified from ES products using differential 
ultracentrifugation following a modified protocol [21]. Briefly, parasite culture media was 
centrifuged at 2,000 g for 30 min at 4C to remove larger debris; supernatant was further 
centrifuged at 15,000 g for 30 min at 4C. ES supernatants were filtered using a 0.2 µm 
membrane (Schleicher and Schuell Bioscience) then ultracentrifuged at 110,000 g for 2 h at 
4C. The pellet was washed in PBS containing protease inhibitor cocktail (Roche) and 
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ultracentrifuged for 1 h. Crude pellet was resuspended in 200 µl PBS/ protease inhibitor 
cocktail and stored at 4C.  
 
Preparation of EVs for Transmission Electron Microscopy 
Five l of purified EVs was applied to a carbon-formvar coated grid and air dried. 
Grids were negatively stained in 2% uranyl acetate for 15 secs. Stained grids were viewed in 
a JEM1011 transmission electron microscope (JEOL) equipped with a Morada side-mounted 
digital camera (Olympus).  
 
Fluorescence labelling of EVs membranes 
EVs were labelled with Alexa Fluor 488 5-SDP Ester (AF488) (Life Technologies) 
following the manufacturer’s protocol. EV pellets were resuspended in 400 µl of PBS and 
mixed with 50 µg of AF488 for 1 h at 4C. The samples were collected by ultracentrifugation 
at 110,000 g for 2 h to remove excess dye, washed twice and resuspended in 400 µl of PBS. 
 
Cell co-cultures and fluorescence microscopy 
 To investigate internalization of EVs by mammalian cells, normal immortalized 
human cholangiocytes (H69) were grown to 80% confluence as described [22]. Cells were 
starved of FCS overnight, incubated with AF488-EVs for 6 h, and analysed by fluorescence 
microscopy. Cell nuclei were stained with Hoechst dye and visualized using an AxioImager 
M2 ApoTome fluorescence microscope (Zeiss). Two technical and 2 biological replicates 
were performed and at least 5 fields were analysed in each replicate. Fluorescence was 
quantified using ImageJ.  
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Ultra-resolution microscopy  
To convincingly demonstrate internalization of O. viverrini EVs by cholangiocytes, we used 
3D-Structured Illumination microscopy (3D-SIM). H69 cholangiocytes were grown to 50% 
confluence and co-cultured with AF488-EVs or an equivalent amount (based on fluorescence) 
of ES products (10 µg/ml) for up to 6 h. Treated cells were fixed in 4% paraformaldehyde, 
permeabilised in 0.1% Triton X-100 in PBS and stained with Alexa Fluor 568 Phalloidin 
(Life Technologies). Specimens were mounted in 5% N-propyl-Gallate (Sigma) and 3D-SIM 
was performed on isolated single cells using a DeltaVision OMX 3D-SIM system (Applied 
Precision Inc, GE Healthcare). Solid state lasers (405, 488, 593 nm) provided wide-field 
illumination and multi-channel images were captured simultaneously using three 512× 512 
pixel size PCO edge scientific CMOS cameras. All data capture used a 60× 1.4 NA oil 
objective and standard excitation and emission filter sets (in nm, 405 EX / 419-465 EM, 488 
EX / 500-550 EM and 592.5 EX / 608-648 EM). 3D-SIM images were sectioned using a 125 
nm Z-step size. Raw 3-phase images were reconstructed as previously described [23]. 
Reconstructed images were rendered in 3D using IMARIS version 7.X (Bitplane Scientific).  
 
Proteomic analysis of EVs 
Sample preparation for proteomic analysis was performed as described [13]. Peptides 
were resuspended in 5% formic acid and analysed by LC-MS/MS. Ten microliters was 
injected onto a C18 trap column (Thermo Scientific Acclaim) and flushed into an analytical 
column (Agilent) and eluted via a mobile phase gradient: 5–80% solvent B over 120 min. The 
eluted material was directly applied to the nanospray source of a QSTAR Elite instrument 
(Applied Biosystems), and data analysis was conducted with Analyst 2.0 (Applied 
Biosystems). 
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iTRAQ analysis 
H69 cells were co-cultured with the quantity of EVs that corresponded to 1.2 µg/ml of 
ES protein in PBS for 30 min, 3 h and 16 h. Cells were washed using PBS containing 
protease inhibitor cocktail and lysed in 5 M urea, 2 M thiourea, 0.1% SDS, 1% triton X-100 
and 40 mM Tris (pH 7.4). Each sample was ground with a TissueLyser II (QIAGEN) and 
centrifuged at 12,000 g for 20 min. The protein supernatant was precipitated with cold 
methanol, centrifuged at 8,000 g and air dried pellets re-dissolved in 0.5 M triethylammonium 
bicarbonate (TEAB)/0.05% SDS, then centrifuged at 12,000 g. Samples were resuspended in 
0.5 M TEAB prior to reduction, alkylation, digestion and iTRAQ labelling (AB Sciex) then 
analysed on a 5600 TripleTOF mass spectrometer as described [24].  
 
Bioinformatic analysis of protein expression data 
For proteomic characterization of O. viverrini EV proteins, the O. viverrini genome 
database [25] was interrogated using MASCOT (Matrix-Science) allowing two missed 
cleavages and mass tolerance of 1.2 Da in MS mode and 0.8 Da on MS/MS product ions. 
Probability (P < 0.05) of FDR was calculated for every search using the MASCOT decoy 
database facility. For iTRAQ, two biological and two technical replicates were conducted. 
Database searches were performed against NCBInr using MASCOT allowing two missed 
cleavages and a mass tolerance of 0.1 Da on MS and MS/MS modes, and results were 
validated using Scaffold v.4.2.1 (Proteome Software). Differentially expressed (dysregulated) 
proteins were determined using a Kruskal-Wallis test and results expressed in log2 ratios. 
Only proteins whose expression level underwent a significant (P < 0.05) log2 fold-change of 
>0.6 or <-0.6 for upregulated and downregulated proteins respectively were further 
considered. KEGG and Reactome functional enrichment analyses for dysregulated proteins 
were performed using KEGGMapper and DAVID [26]. Protein-protein interaction analysis 
was performed using String [27]. 
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Detection of EV proteins in bile of O. viverrini-infected humans and hamsters  
Bile was collected from O. viverrini-infected humans by aspiration of resected 
gallbladders, and experimentally infected and uninfected hamsters (controls) by puncture of 
the gallbladder from euthanized animals, and EVs isolated as described above. Selected 
Reaction monitoring (SRM) was performed on a 5600 TripleTOF to identify O. viverrini EV 
proteins in bile. All analyses were performed using SRM-initiated IDA experiments in which 
a SRM survey scan triggered the acquisition of MS/MS spectra. Skyline 3.1 was used to 
generate SRM transitions and for data analysis.  
 
Cell proliferation 
H69 cholangiocytes were cultured as described above until 80% confluent. Cells were 
starved of FCS overnight and cultured with the amount of EVs that corresponded to 1.2 µg/ml 
of ES protein over 72 h at 37C. Control cells were incubated with 1.2 µg/ml of ES products 
(not ultra-centrifuged) or 1.2 µg/ml BSA for the negative control group. Cell proliferation 
was assessed by measuring cell index (CI) values in real time using an xCELLigence SP 
system and E plates (Acea). Three biological replicates were analysed and a 2-way ANOVA 
was performed. 
 
Blocking internalization of EVs with a recombinant Ov-TSP-1 
AF488-EVs were incubated with mouse -Ov-TSP-1 serum [28] or normal 
mouse serum (NMS) at different dilutions (1:2.5, 1:5, 1:20) at RT for 1 h. EV:antibody 
complexes were added to H69 cells and co-cultured for 6 h. Images were obtained using an 
ECLIPSE Ni-u confocal microscope (Nikon) at 60× magnification. Thirty fields from 2 
biological replicates were analysed and a 1-way ANOVA was performed. Cell fluorescence 
was quantified using ImageJ. 
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IL-6 detection 
H69 cholangiocytes were cultured as above to monitor cell proliferation over 24 h. 
Culture media were collected and centrifuged at 2000 g for 10 min to remove cell debris. IL-6 
levels were quantified using an IL6-ELISA kit (R&D System) following the manufacturer’s 
instructions. Three biological replicates were analysed and statistical analysis was performed 
using a 2-way ANOVA. 
 
Results 
Excretory/secretory products from O. viverrini contain EV-like vesicles 
After filtration and ultracentrifugation of ES products from adult O. viverrini we 
identified microvesicular structures using negative staining in transmission electron 
microscopy (Figure 1). These spherical vesicles had an external diameter of 40-180 nm, 
resembling EVs recently reported from other trematodes [13, 14].   
 
Proteomic analysis of O. viverrini EVs reveals conserved and novel proteins  
O. viverrini EVs were digest d with trypsin and submitted to LC-MS/MS. We 
identified 108 different proteins (Supplementary Table 1), 42 of which were homologous to 
mammalian EV proteins in Exocarta [29], including proteins that are diagnostic of 
mammalian exosomes such as tetraspanins, HSP-70, cytoskeletal, regulatory and trafficking 
proteins. Gene Ontology (GO) analysis of the proteins (Supplementary Figure 1) returned 212 
biological pro ess terms. Pfam analysis identified proteins with an EF hand domain as the 
most frequently represented (Supplementary Figure 1). 
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O. viverrini exosome proteins are identified in bile of infected hosts 
SRM analysis confirmed the presence of specific EV proteins in the bile of O. viverrini 
infected humans and hamsters. Seven of the top 15 proteins identified in the EV proteomic 
analysis (based on number of peptides identified) were successfully quantified 
(Supplementary Figure 2).  
 
O. viverrini EVs are internalized by human cholangiocytes  
We monitored the uptake of AF488-EVs by human cholangiocytes in vitro. Within 60 
min punctate fluorescent structures were detected, the number of which increased markedly 
over 6 h (Figure 2A). Cell fluorescence of all fields from the two biological replicates 
revealed fluorescence coverage of 62.44 ±9.52% and 90.57±4.58% at 0.5 h and 6 h 
respectively. 3D-SIM analysis confirmed the intracellular presence of AF488-EVs within the 
cytoskeletal network of well-separated individual cells as evidenced by their position between 
the basal and apical membranes outlined with phalloidin (Figure 2B, C, Supplementary 
Movie). We attempted to co-localize EVs to defined organelles using specific fluorescent 
markers but did not observe co-localization (not shown), suggestive of a cytoplasmic 
location.  
 
O. viverrini EVs promote cell proliferation and stimulate wound healing and tumorigenic 
pathways in cholangiocytes 
H69 cholangiocytes were incubated for 72 h with (i) crude ES products, (ii) EVs 
purified from rude ES products, or (iii) an irrelevant protein control, Bovine Serum Albumin 
(BSA). We chose BSA as a control rather than EVs from another source because H69 
cholangiocytes produce (and uptake) their own exosomes in culture [30]. ES and EVs both 
induced significant (P < 0.05) cell proliferation compared to BSA-treated control cells 
(Figure 3). A total of 705 proteins containing at least 2 peptides were identified and 
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quantified with a 99.9% protein threshold and 1.2% false discovery rate (FDR) from 6,863 
unique peptides (peptide threshold = 95% and 0.82% FDR) from H69 cholangiocytes that 
were co-cultured with EVs (Supplementary Table 2); a total of 396 proteins from 
cholangiocytes co-cultured with EVs were differentially expressed (P < 0.05 as determined 
using a Kruskal-Wallis test) and presented a fold-difference ≥ 1.5 (log2 ≥ 0.6) at ≥1 time 
point (Supplementary Table 2). The greatest changes in protein expression in EV-co-cultured 
cells compared to control cells occurred after 3 h, where 238 (60.1%) proteins were 
differentially expressed  (fold-difference ≥ 1.5 (log2 ≥ 0.6)) in cells incubated with EVs 
(Figure 4A).  
A total of 274 proteins from EV-treated cells matched homologous proteins in the 
KEGG database associated with 186 distinct biological pathways; 171 of these proteins were 
assigned to 14 Reactome pathways (Supplementary Table 3). The 25 KEGG and Reactome 
pathways associated with the largest numbers of proteins differentially expressed after 
incubation with EVs are shown in Figure 4B and C respectively. The expression of proteins 
linked to four pathways implicated in cancer and wound healing was significantly modified 
by EVs (Figure 4B). Supplementary Table 4 highlights all cholangiocyte proteins and KEGG 
pathways related to cancer and wound healing and their expression following co-culture with 
EVs. A total of 7 proteins involved in the Phagosome pathway were differentially expressed 
following exposure of human cholangiocytes to EVs (Supplementary Figure 3, 
Supplementary Table 5). 
When differentially expressed proteins were assigned to Reactome pathways, those 
associated with Apoptosis, Regulation of activated PAK-2p34 by proteasome, and Cdh1-
mediated degradation of Skp2 pathways were differentially regulated in cholangiocytes co-
cultured with EVs (Figure 4C). Expression of 17 proteins associated with Apoptosis was 
regulated by EVs, and protein-protein interactions revealed that the majority of dysregulated 
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cholangiocyte proteins formed a cluster belonging to the proteasome complex 
(Supplementary Figure 4).  
 
Uptake of EVs and pro-inflammatory cytokine production by cholangiocytes can be blocked 
with antibodies to an O. viverrini EV tetraspanin 
Due to the roles of tetraspanins in the formation of EVs by mammalian cells and their 
subsequent uptake by recipient cells [31], and the recent identification of the Ov-TSP-1 
tetraspanin on the surface of O. viverrini [28], we explored the role of Ov-TSP-1 in the uptake 
of EVs by cholangiocytes. Antiserum to recombinant Ov-TSP-1 blocked the uptake of EVs 
by cholangiocytes compared to normal mouse serum (P < 0.001 – P < 0.0001) (Figure 5). ES 
and EVs both stimulated the secretion of significantly more IL-6 from cholangiocytes than 
did control cells incubated with media alone (P < 0.01 – P < 0.001; Figure 7), and IL-6 
secretion was significantly reduced when EV internalisation was blocked by antiserum to Ov-
TSP-1 (P < 0.05; Figure 6).  
 
Discussion 
While the mechanisms that drive chronic liver fluke infection towards cancer are 
multi-factorial, a pivotal role for fluke ES products in promoting a tumorigenic phenotype has 
been demonstrated [7]. The intracellular localization of O. viverrini ES proteins in 
cholangiocytes of infected hosts has prompted speculation on the mechanisms underlying this 
process of parasite protein internalization and its potential pathologic and carcinogenic 
consequences [6, 7]. Herein we show that O. viverrini secretes EVs that are internalized by 
human cholangiocytes in vitro and trigger a cascade of inflammatory and pro-tumorigenic 
changes within the cell, thereby providing a plausible mechanism by which ES proteins are 
taken up by biliary cells of infected hosts and contribute to the development of CCA in 
infected individuals. 
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Investigations on the interactions between EVs derived from single celled parasites 
and the cells that they encounter in an infected host have shed light on a novel means of host-
parasite cellular communication [11, 12]. Protozoan parasite EVs are also capable of 
modulating pro-inflammatory immune responses and inducing production of regulatory 
cytokines in recipient cells [19]. EV production by helminth parasites however has received 
considerably less attention. A seminal study recently showed that the parasitic nematode 
Heligmosomoides polygyrus secretes exosomes that contain microRNAs which suppress type 
2 innate responses [15]. However, little is known about the production and particularly the 
biological effects of EVs from parasitic flatworms (platyhelminths). EVs were reported in the 
ES products from the flatworms Fasciola hepatica and Echinostoma caproni [13], and more 
recently Dicrocoelium dendriticum [14], and while the authors showed binding of fluke EVs 
to cell lines, neither the functional implications nor in vivo evidence of EV uptake by tissues 
of infected hosts were addressed. We show here for the first time that helminth EVs are 
unequivocally internalized by host cells, and major EV proteins can be detected in the bile of 
naturally infected humans and experimentally infected hamsters. From proteomic analyses, 
we identified 108 proteins from O. viverrini EVs, and only a handful (13) of these had been 
previously identified in a proteomic analysis of the ES products of the fluke [32].  
Cholangiocytes line the bile ducts and provide the first line of defence against 
pathogens in the biliary system. We show here that O. viverrini EVs drive production of IL-6 
from recipient human cholangiocytes, implicating these EVs in the hepatic disease process. 
IL-6 has been asso iated with chronic periductal fibrosis and CCA in opisthorchiasis patients 
[33], and IL-6 has been implicated in the maintenance of a chronic inflammatory milieu that 
could lead to tumorigenesis [34]. O. viverrini EVs were also capable of driving proliferation 
of cholangiocytes, a phenomenon that has been convincingly documented in the hamster 
infection model [35]. This relentless cell proliferation, coupled with other carcinogenic insults 
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such as chronic immunopathology and elevated intake of dietary nitrosamines [2] culminates 
in the establishment of an environment that is conducive to malignant changes.  
Uptake of EVs by cholangiocytes resulted in dysregulated expression of proteins with 
documented roles in wound healing and cancer. Indeed, wound repair has long been 
implicated in tumorigenesis, and there are striking histological and moelcular similarities 
between tumor stroma and wounded tissues [36]. Nineteen KEGG pathways related to cancer 
and wound healing were affected by EVs in human cholangiocytes. Among the proteins 
significantly regulated we found different tropomyosin isoforms, PAK-2 and the tight 
junction protein ZO-2. PAK-2 is an important kinase that mediates tumor cell invasion [37]. 
We also noted that PAK-2 could play an important role in tumour progression by interacting 
with different components of the proteasome and with vimentin, a protein involved in 
maintaining cellular integrity and providing resistance against stress in several epithelial 
cancers [37]. Moreover, tight junction proteins play important roles in cell-cell junction 
assembly and organization, and are up-regulated during cell proliferation and wound healing 
[38].  
Other important cholangiocyte proteins underwent dysregulated expression after co-
culture with EVs, notably proteins involved in the proteasome complex. Most of the proteins 
involved in this complex were upregulated in cholangiocytes exposed to EVs and are known 
to interact with other proteins involved in cancer and wound healing processes. The 
proteasome complex regulates directly or indirectly many important cellular processes, and 
has been suggested as a therapeutic target for cancer [39, 40].  
EV uptake by dendritic cells can be blocked with antibodies to EV tetraspanins [41]. 
Tetraspanins are thought to be involved in the regulation of protein assembly and microRNA 
recruitment in mammalian exosomes [31] and influence cell selectivity [42]. Our findings 
highlight an important role for Ov-TSP-1 in O. viverrini EV uptake by cholangiocytes. 
Although tetraspanins are found on the surface membranes of all exosomes, their discovery 
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here is particularly pertinent due to their abundance on the surface membranes of parasitic 
helminths [43] and their importance in the development of the O. viverrini tegument [28].  
Tetraspanins are efficacious helminth vaccine antigens [44-46], and our findings here suggest 
that the mechanism of vaccine efficacy is linked to interruption of parasite EV uptake by 
recipient host cells in vivo and subsequent disruption of key physiological (and pathological) 
processes.  
Our study describes for the first time the release of EVs in the secreted products of the 
carcinogenic liver fluke, O. viverrini, and highlights the role of fluke EVs in promoting an 
inflammatory yet simultaneously modulatory (wound healing) environment that ultimately 
facilitates the development of biliary cancer. Our findings do however offer hope for the 
eventual control of this debilitating neglected tropical disease by highlighting a key 
physiological process that can be potentially interrupted via subunit vaccines targeting key 
EV surface molecules.  
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FIGURE LEGENDS 
Figure 1. Extracellular vesicles (EVs) secreted by Opisthorchis viverrini. Transmission 
electron micrograph showing the presence of microvesicles after ultracentrifugation of O. 
viverrini excretory/secretory products. EV-like microvesicles of 40-100 nm can be observed.  
 
Figure 2. Internalization of Opisthorchis viverrini secreted extracellular vesicles (EVs) by 
human cholangiocytes. Fluorescence images of Alexa Fluor 488-labeled EVs (green) 
internalized by H69 cholangiocytes (A). Cholangiocytes internalized the EVs within 1 h of 
co-culture and maximum internalization was observed by 6 h. Control cells were incubated 
with PBS. Hoescht dye (blue) was employed to label cell nuclei (A). 3D-Structured 
Illumination microscopy (3D-SIM) fluorescence image of the edge of a well-separated 
individual cholangiocyte after 6 h incubation with Alexa Fluor 488-stained EVs (green) (B). 
Lateral (xy) overview of cell showing EVs present within the cytoskeletal actin network (red) 
of the cell (B). Rendered axial (xz) view of inset in panel A revealed EVs between the apical 
and basal surfaces of the cell that were stained by phalloidin (red) (C). 
 
Figure 3. Opisthorchis viverrini extracellular vesicles (EVs) drive proliferation of human 
cholangiocytes. O. viverrini EVs (open triangles) and excretory/secretory (ES) products 
(closed circles) promot d the proliferation of human cholangiocytes. Asterisks represent the 
time-point from which cell growth remained significantly different between test and control 
groups after each treatment. * P<0.05. 
 
Figure 4. Comparison of proteins that were significantly regulated, and biological 
pathways regulated in cholangiocytes co-cultured with Opisthorchis viverrini 
extracellular vesicles (EVs). (A) Heatmap of the proteins from human cholangiocytes with a 
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significant fold regulation after Kruskal-Wallis test and that underwent a 2-fold-change 
(log2=1.5) in at least one of the time-points assessed after incubation with EVs from O. 
viverrini. (B) Top 25 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways 
regulated after incubation with EVs. (C) Reactome pathways regulated after incubation with 
EVs. Pathways that are involved in wound healing and cancer are indicated by red font. 
 
Figure 5. Blockade of uptake of Opisthorchis viverrini extracellular vesicles (EVs) by 
antibodies to recombinant Ov-TSP-1. Mouse antibodies raised to recombinant Ov-TSP-1 
blocked the uptake of Alexa Fluor 488-labeled O. viverrini EVs by H69 cholangiocytes. 
Fluorescence micrographs of internalized EVs co-cultured with H69 cholangiocytes in the 
presence of anti-Ov-TSP-1 serum (A) or normal mouse serum (NMS) (B) at different 
dilutions. Ov-TSP-1 significantly reduced the binding and internalization of EVs at 
all serum dilutions when measured as fluorescence intensity (C) when compared to NMS (D). 
***P<0.001; ****P<0.0001. 
 
Figure 6. IL-6 production by human cholangiocytes after internalisation of Opisthorchis 
viverrini extracellular vesicles (EVs). Human cholangiocytes produce significantly greater 
levels of IL-6 after co-culture with O. viverrini EVs. IL-6 production was partially blocked 
when EVs were incubated with antibodies against recombinant Ov-TSP-1 prior to cell culture. 
*P<0.05; **P<0.01; ***P<0.001. 
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